hemophilia

Hympavzi

Pharma

FDA signs off on pediatric use of Pfizer's hemophilia treatment

The FDA has expanded the label for Pfizer’s subcutaneous Hympavzi, now including patients age 6 and older who have hemophilia A or B.

Kevin Dunleavy Jun 8, 2026 10:32am

Genentech Hemlibra short film

Genentech shifts Hemlibra marketing focus to patient stories

Apr 20, 2026 9:30am

Believe Limited Sanofi bleeding disorders documentary

Sanofi backs 2 more films about rare blood disorders

Mar 20, 2026 1:04pm

shortages drugs

CSL's Hemgenix in 'temporary global stockout,' company says

Mar 19, 2026 4:35pm

Biomarin

BioMarin pulls gene therapy Roctavian off the market

Feb 24, 2026 12:30pm

Pfizer

Pfizer confirms patient death in hemophilia drug trial

Dec 23, 2025 11:05am